OneMedNet appoints new CFO
September 10, 2024 08:45 ET
|
OneMedNet Corporation
Bob Golden has joined the OneMedNet as Chief Financial Officer spearheading all aspects of the company’s financial and accounting operations.
iLearningEngines CEO Sets the Record Straight
September 10, 2024 08:30 ET
|
iLearningEngines Holdings, Inc.
BETHESDA, Md., Sept. 10, 2024 (GLOBE NEWSWIRE) -- iLearningEngines, Inc. (NASDAQ: AILE) (“iLearningEngines” or “ILE”) a leader in AI-powered learning and work automation for enterprises, provides...
NANO Nuclear Energy Joins the Russell 3000® Index
September 10, 2024 08:30 ET
|
NANO Nuclear Energy Inc.
The Russell 3000 Index is an influential benchmark that captures the performance of the 3,000 largest U.S. public companies New York, N.Y., Sept. 10, 2024 (GLOBE NEWSWIRE) -- NANO...
YY Group Holding Limited Announces Unaudited First Half 2024 Financial Results
September 10, 2024 08:30 ET
|
YY Group Holding Limited
YY Group Holding Limited reported a strong financial performance for the first half of 2024, with revenues growing by 41% to $19.3 million.
Lifeward Announces Appointment of Dr. Keith E. Tansey as Consulting Director of Clinical Research
September 10, 2024 08:30 ET
|
ReWalk Robotics Ltd. (DBA Lifeward)
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Sept. 10, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™) (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader...
Atossa Therapeutics Announces Support of Final Rule from FDA Requiring Patient Notification of Breast Density, a Critical Step in Addressing a Known Risk Factor for Breast Cancer
September 10, 2024 08:30 ET
|
Atossa Therapeutics, Inc.
SEATTLE, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), today announced its support of the U.S. Food and Drug Administration (FDA) for...
Corvus Pharmaceuticals Initiates Registrational Phase 3 Clinical Trial of Soquelitinib for Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma
September 10, 2024 08:30 ET
|
Corvus Pharmaceuticals, Inc.
Soquelitinib is a potential first-in-class ITK inhibitor with broad potential in cancer and immune diseases There are currently no fully approved agents for the treatment of relapsed PTCL and...
Blink Charging to Host ‘CEO to Future CEO’ Fireside Chat on EV Industry Developments and Strategic Vision
September 10, 2024 08:30 ET
|
Blink Charging Co.
On September 12th, 2024, Brendan Jones and Michael Battaglia will host a fireside chat, marking the first joint live discussion since announcing leadership changes coming in 2025. Bowie, MD, Sept. ...
NETSOL Signs Expansion Agreement with Major Automaker Increasing Total Contract Value to Over $30 Million
September 10, 2024 08:30 ET
|
NETSOL Technologies Inc.
ENCINO, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- NETSOL Technologies, Inc. (Nasdaq: NTWK), a global leader in delivering state-of-the-art solutions for the asset finance and leasing industry, has...
Leading Government Defense Ministry Awards BIO-key $500K In Follow-On Orders for Biometric User Authentication
September 10, 2024 08:27 ET
|
BIO-key International, Inc.
One of the world’s most respected government defense ministries has awarded BIO-key over $500K in new orders for biometric user authentication.